This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Assistance Publique-Hopitaux De Paris, National Institute of Health and Medical Research, Universitè De Montpellier. Active years: 2016-2018.
Company Filing History:
2 out of 331 
2 out of 1,853 
2 out of 297 
Years Active: 2016-2018
Title: Raffaella Soleti: Innovator in Cardioprotection
Introduction
Raffaella Soleti is a notable inventor based in Angers, France. She has made significant contributions to the field of cardioprotection, particularly in the treatment of myocardial infarction. With a total of 2 patents, her work focuses on innovative methods that leverage the sonic hedgehog signaling pathway.
Latest Patents
Raffaella Soleti's latest patents include methods for treating myocardial infarction that involve administering sonic hedgehog. The inventions relate to pharmaceutical compositions aimed at providing cardioprotection for subjects who have experienced a myocardial infarction. These methods utilize a ligand of the sonic hedgehog signaling pathway to enhance recovery and protect the heart.
Career Highlights
Throughout her career, Raffaella has worked with esteemed institutions such as Université Paris Est Créteil Val De Marne and Assistance Publique-Hôpitaux de Paris. Her research has been pivotal in advancing the understanding and treatment of heart conditions.
Collaborations
Raffaella has collaborated with notable colleagues, including Jean-Yves Le Guennec and Maria Del Carmen Martinez. These partnerships have contributed to her innovative research and development in the field.
Conclusion
Raffaella Soleti stands out as an influential inventor in the realm of cardioprotection, with her groundbreaking patents paving the way for new treatment methodologies. Her dedication to advancing medical science is evident in her work and collaborations.